Sansure Biotech Inc (SHG:688289) — Market Cap & Net Worth
Market Cap & Net Worth: Sansure Biotech Inc (688289)
Sansure Biotech Inc (SHG:688289) has a market capitalization of $1.19 Billion (CN¥8.15 Billion) as of June 23, 2026. Listed on the SHG stock exchange, this China-based company holds position #8299 globally and #2019 in its home market, demonstrating a -4.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sansure Biotech Inc's stock price CN¥14.07 by its total outstanding shares 579388006 (579.39 Million). Review Sansure Biotech Inc balance sheet liabilities to assess the company's total debt and financial obligations.
Sansure Biotech Inc Market Cap History: 2020 to 2026
Sansure Biotech Inc's market capitalization history from 2020 to 2026. Data shows change from $5.75 Billion to $1.19 Billion (-23.86% CAGR).
Sansure Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sansure Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.97x
Sansure Biotech Inc's market cap is 0.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.09x
Sansure Biotech Inc's market cap is 8.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $5.75 Billion | $4.76 Billion | $2.62 Billion | 1.21x | 2.20x |
| 2021 | $3.03 Billion | $4.51 Billion | $2.24 Billion | 0.67x | 1.35x |
| 2022 | $1.75 Billion | $6.45 Billion | $1.94 Billion | 0.27x | 0.90x |
| 2023 | $1.62 Billion | $1.01 Billion | $363.72 Million | 1.60x | 4.44x |
| 2024 | $1.92 Billion | $1.46 Billion | $275.60 Million | 1.32x | 6.98x |
| 2025 | $1.60 Billion | $1.65 Billion | $198.15 Million | 0.97x | 8.09x |
Competitor Companies of 688289 by Market Capitalization
Companies near Sansure Biotech Inc in the global market cap rankings as of June 23, 2026.
Key companies related to Sansure Biotech Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #162 globally with a market cap of $144.07 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #268 globally with a market cap of $93.95 Billion USD ( €80.36 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #337 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #541 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Intuitive Surgical Inc | NASDAQ:ISRG | $144.07 Billion | $406.78 |
| #268 | EssilorLuxottica S. A. | PA:EL | $93.95 Billion | €173.55 |
| #337 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €87.50 |
| #541 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Sansure Biotech Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Sansure Biotech Inc's market cap moved from $5.75 Billion to $ 1.19 Billion, with a yearly change of -23.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.19 Billion | -25.60% |
| 2025 | CN¥1.60 Billion | -16.70% |
| 2024 | CN¥1.92 Billion | +19.11% |
| 2023 | CN¥1.62 Billion | -7.49% |
| 2022 | CN¥1.75 Billion | -42.31% |
| 2021 | CN¥3.03 Billion | -47.32% |
| 2020 | CN¥5.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Sansure Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.19 Billion USD |
| MoneyControl | $1.19 Billion USD |
| MarketWatch | $1.19 Billion USD |
| marketcap.company | $1.19 Billion USD |
| Reuters | $1.19 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sansure Biotech Inc
Sansure Biotech Inc. researches and develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tr… Read more